Sensei Biotherapeutics Faces Nasdaq Delisting Warning
Ticker: SNSE · Form: 8-K · Filed: Jan 7, 2025 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Jan 7, 2025 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, stock-price
Related Tickers: NASDAQ:SNS
TL;DR
Sensei Biotherapeutics is at risk of being delisted from Nasdaq due to its stock price falling below $1.00 for 30 days straight.
AI Summary
Sensei Biotherapeutics, Inc. filed an 8-K on January 7, 2025, to report its failure to meet Nasdaq's minimum bid price requirement. The company was notified by Nasdaq on January 3, 2025, that its common stock had a closing bid price of less than $1.00 for 30 consecutive business days, violating Listing Rule 5450(a)(2). Sensei Biotherapeutics has 180 days, until July 1, 2025, to regain compliance.
Why It Matters
Failure to regain compliance with Nasdaq's minimum bid price requirement could lead to the delisting of Sensei Biotherapeutics' common stock, impacting its liquidity and investor confidence.
Risk Assessment
Risk Level: high — The company has received a formal notification from Nasdaq regarding its failure to meet the minimum bid price requirement, putting its listing status in jeopardy.
Key Numbers
- $1.00 — Minimum Bid Price (Nasdaq's requirement for continued listing)
- 30 — Consecutive Business Days (Duration below minimum bid price)
- 180 — Days to Regain Compliance (Grace period provided by Nasdaq)
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- Nasdaq (company) — Stock Exchange
- January 7, 2025 (date) — Filing Date
- January 3, 2025 (date) — Notification Date
- July 1, 2025 (date) — Compliance Deadline
- $1.00 (dollar_amount) — Minimum Bid Price Requirement
FAQ
What specific Nasdaq rule did Sensei Biotherapeutics violate?
Sensei Biotherapeutics violated Nasdaq Listing Rule 5450(a)(2), which requires a minimum closing bid price of $1.00 per share.
When was Sensei Biotherapeutics notified of its non-compliance?
The company was notified by Nasdaq on January 3, 2025.
What is the deadline for Sensei Biotherapeutics to regain compliance?
The company has until July 1, 2025, to regain compliance with the minimum bid price requirement.
What is the consequence if Sensei Biotherapeutics fails to regain compliance?
If the company fails to regain compliance, its common stock may be delisted from the Nasdaq Capital Market.
What actions can Sensei Biotherapeutics take to regain compliance?
The company can regain compliance by having its common stock achieve a closing bid price of $1.00 or greater for a minimum of 10 consecutive business days during the compliance period.
Filing Stats: 766 words · 3 min read · ~3 pages · Grade level 13.5 · Accepted 2025-01-07 17:18:03
Key Financial Figures
- $1.00 — Company's common stock had closed below $1.00 per share, the minimum closing bid pric
Filing Documents
- d909848d8k.htm (8-K) — 29KB
- 0001193125-25-002920.txt ( ) — 187KB
- snse-20250107.xsd (EX-101.SCH) — 4KB
- snse-20250107_def.xml (EX-101.DEF) — 14KB
- snse-20250107_lab.xml (EX-101.LAB) — 23KB
- snse-20250107_pre.xml (EX-101.PRE) — 15KB
- d909848d8k_htm.xml (XML) — 5KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sensei Biotherapeutics, Inc. Date: January 7, 2025 By: /s/ Christopher W. Gerry Christopher W. Gerry General Counsel and Secretary